Literature DB >> 18027317

Non-erosive reflux disease (NERD) and erosive esophagitis--a spectrum of disease or special entities?

R Fass1.   

Abstract

An understanding of the natural history of GERD has an important impact on the long-term management of the disorder. By assessing the currently available studies that evaluated the natural course of GERD, a new conceptual framework that suggests that GERD is composed of three distinct phenotypic presentations has been recently proposed. Presently, the field has been divided into two camps that support or oppose a paradigm shift in the natural course of GERD. Nevertheless, the largest population-based or longest duration natural course studies report only 10% progress from NERD to erosive esophagitis over time. The other GERD patients remained within their respective phenotypic presentation of GERD.

Entities:  

Mesh:

Year:  2007        PMID: 18027317     DOI: 10.1055/s-2007-963628

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  9 in total

Review 1.  Excess Body Weight and Gastroesophageal Reflux Disease.

Authors:  Andreas Thalheimer; Marco Bueter
Journal:  Visc Med       Date:  2021-05-07

2.  Nonerosive Reflux Disease (NERD) - An Update.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 3.  Alternative Treatments for Minor GI Ailments.

Authors:  A K Mohiuddin
Journal:  Innov Pharm       Date:  2019-07-05

Review 4.  Current Trends in the Management of Gastroesophageal Reflux Disease.

Authors:  Dalbir S Sandhu; Ronnie Fass
Journal:  Gut Liver       Date:  2018-01-15       Impact factor: 4.519

5.  Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease.

Authors:  Nicolaas F Rinsma; Ricard Farré; Fred J Troost; Montserrat Elizalde; Daniel Keszthelyi; Zsuzsanna Helyes; Ad A Masclee; José M Conchillo
Journal:  Int J Mol Sci       Date:  2017-05-19       Impact factor: 5.923

6.  Analysis of gastric microbiota and Helicobacter pylori infection in gastroesophageal reflux disease.

Authors:  Titong Sugihartono; Kartika Afrida Fauzia; Muhammad Miftahussurur; Langgeng Agung Waskito; Purwo Sri Rejeki; Reny I'tishom; Ricky Indra Alfaray; Dalla Doohan; Rizki Amalia; Camilia Metadea Aji Savitri; Yudith Annisa Ayu Rezkitha; Junko Akada; Takashi Matsumoto; Yoshio Yamaoka
Journal:  Gut Pathog       Date:  2022-09-13       Impact factor: 5.324

7.  Antireflux surgery is equally beneficial in nonerosive and erosive gastroesophageal reflux disease.

Authors:  Joong-Min Park; Kyong-Choun Chi
Journal:  Ann Surg Treat Res       Date:  2017-07-30       Impact factor: 1.859

8.  Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study.

Authors:  Chan Hyuk Park; Seung In Seo; Joon Sung Kim; Sun Hyung Kang; Beom Jin Kim; Yoon Jin Choi; Hyo Joo Byun; Jung-Ho Yoon; Sang Kil Lee
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379

9.  Gastroesophageal reflux disease in a typical African population: a symptom-based multicenter study.

Authors:  Sylvester Chuks Nwokediuko; Olusegun Adekanle; Adegboyega Akere; Abdulfatai Olokoba; Chiedozie Anyanechi; Sabo Mustapha Umar; Abubakar Maiyaki; Uchenna Ijoma; Olive Obienu; Augustine Uhunmwangho; Dennis Ndububa
Journal:  BMC Gastroenterol       Date:  2020-04-15       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.